OnCore Login

September 2017

Big Ten Cancer Research Consortium opens endometrial cancer clinical trial

Sept. 25, 2017:

The Big Ten Cancer Research Consortium (Big Ten CRC) announces the opening of a clinical trial for patients with advanced or recurrent endometrial cancer.

The study, known as BTCRC-GYN15-013, involves pembrolizumab, one of a new class of drugs called PD-1 inhibitors, given in combination with routine care using paclitaxel and carboplatin chemotherapy. [Pictured: Study sponsor-investigator Daniela Matei, MD of Northwestern University Feinberg School of Medicine.]

The Robert H. Lurie Comprehensive Cancer Center of Northwestern University in Chicago is currently enrolling subjects in this study. Additional member sites within the Big Ten Cancer Research Consortium will open the trial in the coming months. Read More

Across the Consortium – September 2017

Sept. 20, 2017:

Each month, the Big Ten Cancer Research Consortium highlights advances in research and treatment led by our member institutions. Following are recent developments from Across the Consortium:

Read More

University of Illinois

University of Illinois

Indiana University

Indiana University

University of Iowa

University of Iowa

University of Maryland

University of Maryland

University of Michigan

University of Michigan

Michigan State

Michigan State

University of Minnesota

University of Minnesota

University of Nebraska

University of Nebraska

Northwestern University

Northwestern University

Penn State University

Penn State University

Purdue University

Purdue University

Rutgers State University

Rutgers State University

University of Wisconsin

University of Wisconsin

University of Illinois at Chicago

University of Illinois at Chicago

© 2024 All rights reserved.

Big Ten Cancer Research Consortium
7676 Interactive Way, Suite 120, Indianapolis, IN 46278

email: info@bigtencrc.org    phone: 317–921–2050